• Form Bio will hold an extraordinary shareholders meeting on Nov. 10, 2026, at Digital Empire II in Suwon.
• Shareholders will vote on charter amendments allowing targeted share issuance for management purposes, including technology acquisition or financial restructuring.
• The proposals also permit convertible bond issuance of up to 50 billion won to specified investors for those purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Form Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000293), on October 26, 2026, and is solely responsible for the information contained therein.